Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 55.6%
Negative

Negative
The Motley Fool
9 days ago
Luminus Trims Its Hefty Chemours Position
Luminus Management LLC reduced its stake in The Chemours Company (CC -1.86%) during Q3 2025, selling shares worth an estimated $4.30 million, based on the average quarterly price, according to an SEC filing dated October 3, 2025.
Luminus Trims Its Hefty Chemours Position
Neutral
MarketBeat
11 days ago
3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Price action is one of the most important metrics to watch out for when deciding whether a potential investment setup is bullish or bearish. However, despite its importance, price action is only half the picture because relying solely on it without linking to fundamental reasons risks capital blindly.
3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Neutral
Business Wire
1 month ago
Chemours Announces Board Leadership Appointments: Mary Cranston Named Chair, Alister Cowan Named Lead Independent Director
WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) today announced that its Board of Directors has appointed Independent Director Mary Cranston as Chair of the Board and Alister Cowan to the role of Lead Independent Director, effective September 2, 2025. These appointments follow the departure of Dawn Farrell, who has accepted a position with the Canadian government as the Chief Executive Officer of the newly created Major Projects Office under the Building Canada Act. “While.
Chemours Announces Board Leadership Appointments: Mary Cranston Named Chair, Alister Cowan Named Lead Independent Director
Neutral
Business Wire
1 month ago
Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals.
Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals
Positive
Zacks Investment Research
1 month ago
Chemours Enters Strategic Agreement With SRF to Boost Supply
CC partners with SRF to expand global supply chain, boost operational flexibility and strengthen its high-value product mix.
Chemours Enters Strategic Agreement With SRF to Boost Supply
Neutral
Business Wire
1 month ago
Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026.
Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026
Neutral
Business Wire
2 months ago
Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid.
Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid
Positive
Zacks Investment Research
2 months ago
Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes
CC posts Q2 earnings and sales beat driven by volume and pricing gains, but issues softer sequential guidance.
Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes
Positive
Seeking Alpha
2 months ago
Chemours: Solid Q2 And Legal Progress Are Bullish (Rating Upgrade)
Chemours is showing financial improvement, especially in Opteon refrigerants, despite industry headwinds and a recent dividend cut. The company's legal overhang is easing after a favorable New Jersey PFAS settlement, freeing up future cash flow and reducing uncertainty. Balance sheet leverage remains high, but improving free cash flow in the second half should reduce net debt and support the current dividend.
Chemours: Solid Q2 And Legal Progress Are Bullish (Rating Upgrade)
Positive
The Motley Fool
2 months ago
Chemours (CC) Q2 EPS Jumps 53%
Chemours (CC) Q2 EPS Jumps 53%
Chemours (CC) Q2 EPS Jumps 53%